Latest Press Releases

CG Oncology Announces Pricing of Upsized Initial Public Offering

IRVINE, Calif.--(BUSINESS WIRE)--CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer, today announced...

Upcoming Conferences

ASCO-GU
We’ll be attending ASCO-GU in San Francisco in January 2024,
and we look forward to connecting with you at the event. 

contact: information@cgoncology.com

Media Contact

Bing Kung
Vice President, Business Development
CG Oncology
bd@cgoncology.com
Kimberly Ha
KKH Advisors
(917) 291-5744
kimberly.ha@kkhadvisors.com